Optune Lua: The Newest Advancement in Tumor Treating Fields Technology for Malignant Pleural Mesothelioma

June 16, 2020 By Erika R. Whitehead

In May, Optune Lua became the first FDA approved Tumor Treating Fields device designed for use with standard dual drug chemotherapy for patients diagnosed with inoperable malignant pleural mesothelioma. Previously named the NovoTTF-100L System, the portable device was created by Novocure, a global oncology company leading the way in new therapies for solid tumors. Optune…